Jinhe Biotechnology Co.,Ltd.’s Net Profit Rose 2% in First Three Quarters of 2022
Listen to the full version

Jinhe Biotechnology Co.,Ltd. (金河生物科技股份有限公司) (002688.SZ) reported a net profit of 138.1 million yuan in the first three quarters of 2022, up 2% year-on-year.
Meanwhile, the company posted 1.6 billion yuan in revenue, up 13.5% year-on-year.
At the end of the reporting period, it had 4.6 billion yuan in total assets and 1.9 billion yuan in total liabilities, with a liability-to-asset ratio of 40.4%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR